Amarin Corp Plc (AMRN)

[jessellivermore]

"the science regarding inflammation, just that it is not accepted in the medical community at this time or any time soon"

I understand you are offering this as an opinion. Actually it is accepted by the medical community at present. It is probabably not acted on, or used to frame therapeutic decisions by busy PCPs at present, but that is likely to change in the near future. The reason for the shift will be the entry of Vascepa (EPA) into the diabetic field..

The ANCHOR indication will "green light" Vascepa for diabetics..Diabetics about 25million in the USA are living under a sword, and even if their doctors are too lazy, too entrenched to learn about Vascepa, their patients will be motivated and educated (by the internet..not drug reps)..to demand Vascepa, because there is class A (a peer reviewed outcome study) evidence that EPA cuts down their risk of dying..

":>) JL.